Takeda Pharmaceutical Company Limited (TAK)
Healthcare · Drug Manufacturers - Specialty & Generic
2 members of Congress have disclosed 4 trades in Takeda Pharmaceutical Company Limited (TAK) since 2023: 2 buys and 2 sales. The most recent was disclosed on Sep 5, 2023.
- Trades disclosed
- 4
- Members trading
- 2
- Buys / sells
- 2 / 2
- Reported value
- $32K–$130K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at TAK
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.
Who traded TAK
- Rep. Virginia Foxx (R-NC-5)1 buy · 1 sale11Sep 5, 2023
- Rep. Daniel S. Goldman (D-NY-10)1 buy · 1 sale11Aug 13, 2023
All trades
- Sep 5, 2023$15K–$50K
Rep. Virginia Foxx (R-NC-5)
Sold Takeda Pharmaceutical Company Limited TAK
$15K–$50K · Traded Aug 29, 2023 · disclosed Sep 5, 2023 · Joint
- Aug 13, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Sold Takeda Pharmaceutical Company Limited TAK
$15K–$50K · Traded Jul 10, 2023 · disclosed Aug 13, 2023
- Mar 20, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Bought Takeda Pharmaceutical Company Limited TAK
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
- Mar 3, 2023$1K–$15K
Rep. Virginia Foxx (R-NC-5)
Bought Takeda Pharmaceutical Company Limited TAK
$1K–$15K · Traded Feb 16, 2023 · disclosed Mar 3, 2023 · Joint
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.